Cooper Companies (The) (COO) : The total money flow in Cooper Companies (The) (COO) was negative ($5.69 million), which signals selling by the traders on Tuesdays session. They trimmed their holdings by selling the stock on downticks to the tune of $13.22 million. In comparison, the inflow of money into the stock on upticks was $7.53 million. The uptick to downtick ratio was 0.57. Similarly, the block trades show selling by large traders on strength. The value of stocks sold down on downtick was $5.6 million. The negative money flow of ($5.6 million) confirms the selling in Cooper Companies (The) (COO) on strength. Cooper Companies (The) (COO) gained $0.17 at $186.73, a gain of 0.09% over the previous days close. However, the stock registered 1.53% in the week.
Also, Equity Analysts at the Brokerage Firm, Jefferies, maintains their rating on the shares of Cooper Companies (The) (NYSE:COO). Jefferies has a Buy rating on the shares. As per the latest research report, the brokerage house raises the price target to $210 per share from a prior target of $190. The rating by the firm was issued on August 24, 2016.
Shares of The Cooper Companies Inc. rose by 0.32% in the last five trading days and 2.06% for the last 4 weeks. The Cooper Companies Inc. is up 12.55% in the last 3-month period. Year-to-Date the stock performance stands at 38.94%.
Cooper Companies (The) (NYSE:COO): The stock opened at $186.31 on Tuesday but the bulls could not build on the opening and the stock topped out at $187.77 for the day. The stock traded down to $185.19 during the day, due to lack of any buying support eventually closed down at $186.38 with a loss of -0.10% for the day. The stock had closed at $186.56 on the previous day. The total traded volume was 283,417 shares.
In a related news,The director of Cooper Companies Inc, Kalkstein Michael sold 1,000 shares at $178.55 on July 8, 2016. The Insider selling transaction had a total value worth of $178,550. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.
The Cooper Companies, Inc. (Cooper), is a global medical device company. The Company operates through two business units, CooperVision, Inc. (CVI) and CooperSurgical, Inc. (CSI). CooperVision is a global manufacturer providing products for contact lens wearers. CooperSurgical focuses on supplying womens health clinicians with products and treatment options to improve the delivery of healthcare to women. CooperSurgical products fall into three main segments based on the point of healthcare delivery: Hospital, Office and Fertility Clinic. CooperVision develops, manufactures and markets a range of monthly, two-week and single-use contact lenses, featuring advanced materials and optics. CooperVision is involved in correcting vision problems such as astigmatism, presbyopia and ocular dryness, and provides innovative contact lens solutions. The CooperVision Companys brands include Biofinity, Avaira and MyDay and CooperSurgical Companys brands include Advincula Arch, SeeClear and Mobius.